| Spirig HealthCare AG - Rivaroxaban vascular Spirig HC 2.5 mg, Filmtabletten | | 68551 | | 01 | | Rivaroxaban vascular Spirig HC 2.5 mg | | Filmtabletten | | B01AF01 | | Rivaroxaban | | 16.03.2023 | | |
| | Composition | | rivaroxabanum 2.5 mg, cellulosum microcristallinum, lactosum monohydricum 58.03 mg, povidonum K 30, amylum pregelificatum, crospovidonum, natrii laurilsulfas, magnesii stearas, Überzug: hypromellosum, E 171, macrogolum 4000, E 172 (flavum), pro compresso obducto corresp. natrium 0.053 mg. | | Packungsbestandteile | | Coated tablets | | | | Active Agent | Dose |
|---|
| Rivaroxabanum | 2.5 mg |
| | | | Inactive agents | Dose | additional_information |
|---|
| (Flavum) | | | | Amylum Pregelificatum | | | | Cellulosum Microcristallinum | | | | Crospovidonum | | | | E 171 | | color. | | E 172 | | color. | | Hypromellosum | | Überzug | | Lactose Monohydrate | 58.03 mg | | | Macrogol | 4000 | | | Magnesii Stearas | | | | Natrii Laurilsulfas | | | | Povidonum K | 30 | | | Pro Compresso Obducto | | |
|
| | Package number | Package Size | EFP | CP | Category | SL | Out of trade (MedRef) |
|---|
| 001 | 56 | PR | PR | B | | No | | 002 | 196 | PR | PR | B | | No |
|
|
